SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Acquisition

30 Jul 2007 07:01

Rentokil Initial PLC30 July 2007 30 July 2007 Rentokil Initial to acquire major regional US pest control company Rentokil Initial plc (LSE: RTO) announces that it has entered into an agreementfor the acquisition of the business and assets of Presto-X-Company from itsprivate owners for an initial cash consideration of US$38 million (£19 million)plus further cash consideration of up to $7 million (£3.5 million) based on theactual results for the year to 31 December 2007. Presto-X is a significantregional pest control company based in Omaha, Nebraska, USA, focusedpredominantly on commercial customers. Its turnover for the 12 months to 31December 2006 was US$29 million. Presto-X has 300 employees and operates from 21 branches within the centralstates of the USA including Denver, Dallas, Memphis, St Louis, Kansas City,Chicago and Oklahoma City. It is an excellent operational fit with Rentokil'sexisting North American operations, which operate from 56 branches, primarilyacross the eastern US states. Both organisations are shareholders in Copesan,an alliance of companies created to provide pest management solutions tocustomers with locations across North America. Doug Flynn, Chief Executive of Rentokil Initial, said: "Today's announcement is fully in line with our strategy in North America ofacquiring quality regional companies which expand our footprint, build densityin core regions and improve returns in this growing market. This follows thesuccessful acquisition and integration of JC Ehrlich, America's fourth largestpest control company, in 2006. Our business in North America continues tostrengthen its position in the world's largest pest control market." Ends Notes to Editors Rentokil Initial is one of the largest business services companies in the world,operating in all the major economies of Europe, North America, Asia Pacific andAfrica. The company provides a wide range of support services in over 40countries where the 'Rentokil' and 'Initial' brands represent innovation, deepexpertise and consistent quality of service. Services include textiles andwashroom services, pest control, office plants and artwork, parcels delivery andfacilities services. Rentokil operates pest control services in 38 countries, covering every majoreconomic centre around the world. In 2006, Rentokil Pest Control revenues were£280 million, up 33.7%, of which the USA accounted for 28%. Presto-X management has been at the forefront of the pest control industry inthe USA. Co-owner Ward Combs was previously President of the National PestManagement Association, while Co-owner Jerry Keown was long-time Chairman of theGovernment Affairs Committee of NPMA and was recently honoured for his servicein that capacity. For further information, please contact Rentokil Initial plc Malcolm Padley, Corporate Communications - 020 7866 3027/ 07788 978 199 Lisa Williams, Investor Relations - 020 7866 3028/07980 895 419 Brunswick Group Kate Holgate - 020 7404 5959/07974 982402 Tom Williams - 020 7404 5959/07834 502 361 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Mar 20211:16 pmRNSTotal Voting Rights
31st Mar 202110:33 amRNSAnnual Financial Report
30th Mar 20216:23 pmRNSDirector Declaration
24th Mar 20215:55 pmRNSDirector/PDMR Shareholding
12th Mar 20219:00 amRNSAdditional Listing
4th Mar 20217:05 amRNSDirectorate Change
4th Mar 20217:00 amRNSFinal Results
17th Feb 20215:45 pmRNSDirector Declaration
8th Jan 20217:00 amRNSQ4 2020 Acquisitions and Trading Update
27th Nov 20202:25 pmBUSEarly Repurchase(s)
27th Nov 20202:22 pmBUSEarly Repurchase(s)
24th Nov 20205:25 pmRNSDirector/PDMR Shareholding
20th Nov 20207:00 amRNSResult of Tender Offer for Notes due 2021
12th Nov 20209:02 amRNSTender Offer for Notes due 2021
22nd Oct 20207:00 amRNSQ3 Trading Update
8th Oct 20207:00 amRNSSuccessful EUR600m 8-year bond transaction priced
1st Oct 20209:00 amRNSBlock listing Interim Review
28th Aug 20203:40 pmRNSDirector/PDMR Shareholding
7th Aug 20205:24 pmRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSInterim Results
6th Jul 20207:00 amRNSDirectorate Change
21st May 202011:00 amRNSDirector/PDMR Shareholding
13th May 20205:15 pmRNSResult of AGM
7th May 20204:45 pmRNSDirector/PDMR Shareholding
27th Apr 20203:50 pmRNSDisclosure of Rights Attached to Equity Shares
17th Apr 202011:59 amRNSDirector/PDMR Shareholding
16th Apr 20207:00 amRNSQ1 Trading Update
14th Apr 20205:26 pmRNSHolding(s) in Company
9th Apr 20204:35 pmRNSDirector/PDMR Shareholding
2nd Apr 20201:36 pmRNSDirector/PDMR Shareholding
1st Apr 20205:33 pmRNSConfirmation of Non-Executive Director Appointment
1st Apr 20209:24 amRNSBlock listing Interim Review
31st Mar 20202:18 pmRNSTotal Voting Rights
30th Mar 202012:37 pmRNSRedemption of 4.5% debenture stock
30th Mar 202012:24 pmRNSRedemption of 5% debenture stock
27th Mar 202011:00 amRNSHolding(s) in Company
26th Mar 20204:41 pmRNSSecond Price Monitoring Extn
26th Mar 20204:36 pmRNSPrice Monitoring Extension
26th Mar 202011:29 amRNSAnnual Financial Report
25th Mar 20207:00 amRNSTrading Update
19th Mar 202011:30 amRNSDirector Declaration
17th Mar 20201:15 pmRNSAdditional Listing
6th Mar 202012:00 pmRNSHolding(s) in Company
27th Feb 20207:05 amRNSDirectorate Change
27th Feb 20207:00 amRNSFinal Results
21st Feb 20204:00 pmRNSHolding(s) in Company
24th Dec 20191:10 pmRNSHolding(s) in Company
19th Dec 20192:40 pmRNSDirector/PDMR Shareholding
17th Dec 20195:10 pmRNSHolding(s) in Company
26th Nov 20196:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.